Aug 14 (Reuters) - Pfizer PFE.N :
* To sell four pharmaceutical products to resolve competition concerns
following its acquisition of Hospira (NYSE:HSP)
* Competition Bureau says Pfizer will sell the Canadian assets related to its
marketed injectable cytarabine products
* Competition Bureau says Pfizer will also sell the Canadian assets related to
its injectable epirubicin products, oral tablet methotrexate products
* Source text for Eikon ID:nCNWx4LRwa
* Further company coverage PFE.N